Immune responses can effectively control some human cancers; therapeutically harnessing these responses can fundamentally impact the lives of those who have cancer or are at risk of developing it. Roswell Park is a national leader in the development of immunotherapies offered at only a few select comprehensive cancer centers nationally as well as in contributing to the efforts to diagnose, treat and prevent COVID infections.
Instructor: Sharon Evans, PhD, Professor of Oncology, Roswell Park Comprehensive Cancer Center
